HUMAN SERA, PLASMA AND MORE

Human Serum & Plasma - Certified Quality for Research, Cell Culture & Diagnostics

Human serum is one of the most important biological raw materials in modern life science research. From cell culture and immunology to in vitro diagnostics and cell therapy – human serum provides the physiological environment that animal-derived sera like FBS cannot replicate for human-derived cell systems.

SeamlessBio supplies a comprehensive range of human serum and plasma products sourced from certified donor centers in the European Union and the United States. All products are sterile filtered, extensively viral screened, and fully traceable from donor to delivery.

Our Human Serum Portfolio at a Glance

Product

Blood Group

Winning process

Human Serum – Mixed Gender OTC

Mixed (all blood groups)

Off-the-Clot

Human Serum – Off-the-Clot

Mixed (all blood groups)

Off-the-Clot

Human Serum – Type AB (Mixed Donors)

AB

Off-the-Clot / Plasma-derived

Human Serum – Type AB (Male Donor)

AB

Sterile filtered

Human Serum – Off the Clot Type AB (Male Donor)

AB

Off-the-Clot

Human Serum Albumin (HSA)

N/A

Purified protein


Why Human Serum?

When working with human-derived cells, using human serum instead of fetal bovine serum (FBS) offers several critical advantages:

  • Species-matched physiology: human serum provides growth factors, hormones, and proteins that are native to the human cellular environment
  • No xenogenic immunoreactivity: eliminates the risk of immune reactions triggered by bovine-derived components
  • Regulatory alignment: preferred or required in many cell therapy and clinical research protocols
  • Better spheroid formation and cell invasion studies: studies have shown superior performance vs. FBS for sensitive human cell types
  • Mandatory for certain immune cell types: macrophages, lymphocytes, NK cells, and dendritic cells often require human serum for optimal growth

Understanding the Different Human Serum Types

Off-the-Clot (OTC) vs. Plasma-Derived

Off-the-clot serum is collected from whole blood that is allowed to coagulate naturally without anticoagulants. During natural clotting, platelets contract and release their intracellular contents – resulting in higher levels of growth factors such as PDGF and EGF. OTC serum is the preferred choice for cell culture applications where maximum growth support is needed.

Plasma-derived serum is produced by treating anticoagulated plasma with calcium chloride to initiate coagulation. It has a more defined and stable protein profile, making it suitable for assay development and diagnostic matrix applications where reproducibility is paramount.

Type AB vs. Mixed Blood Group

Human serum from AB-blood-group donors contains no anti-A or anti-B antibodies, eliminating the risk of blood-group-specific immune reactions when culturing cells from donors of any blood type. AB serum is the standard choice in cell therapy, NK cell expansion, CAR-T manufacturing, MSC culture, and any application where immune neutrality is required.

Mixed blood group serum (all blood types pooled) is suitable for most standard human cell culture applications and represents the more cost-effective option when AB specificity is not required.

Male Donor vs. Mixed Gender

Serum from exclusively male donors eliminates variability introduced by cyclic fluctuations in female sex hormones (estradiol, progesterone). For reproducibility-critical experiments and GMP-adjacent workflows, male-donor serum provides more consistent results lot-to-lot.

Key Applications

  • Human primary and continuous cell line culture (HeLa, HEK293, Jurkat, PBMCs, and others)
  • NK cell expansion and hematopoietic stem cell culture
  • CAR-T cell manufacturing and T cell activation
  • Mesenchymal stem cell (MSC) expansion from adipose tissue and bone marrow
  • Pre-transplant human islet culture
  • ELISA development and validation – human-compatible serum matrix
  • IVD diagnostics – controls, calibrators, and clinical chemistry validation matrices
  • Immunohistochemistry and Western blot blocking
  • Cytotoxicity testing (ISO 10993-5)
  • Hybridoma culture and antibody production

Quality Standards & Documentation

Every batch of SeamlessBio human serum undergoes comprehensive quality testing before release:

  • Viral screening: HIV-1/2 Ag/Ab combo, HBsAg, anti-HCV, Syphilis, NAT (where applicable)
  • Sterility testing: 0.1–0.2 µm sterile filtration, confirmed mycoplasma-free
  • Physicochemical parameters: pH, osmolality, total protein, hemoglobin
  • Endotoxin: ≤ 5–10 EU/mL depending on grade

Full documentation is provided with every order: Certificate of Analysis (CoA), Certificate of Origin (COO), Safety Data Sheet (MSDS). Batch reservation available for up to 6 weeks with free storage.

Frequently Asked Questions

Which human serum is right for cell therapy applications?

For cell therapy, NK cell expansion, CAR-T and MSC culture, we recommend Human Serum Type AB from Male Donors, Off-the-Clot. This product combines the immunological advantages of AB blood type (no anti-A/B antibodies), maximum growth factor content (OTC collection), and minimal hormonal variability (male donors only).

Can I switch my cells from FBS to human serum?

Yes. We recommend a stepwise adaptation: culture for 4–6 days with 5% FBS + 5% human serum, then switch to 2% FBS + 8% human serum, and finally to 100% human serum (typically 5–10% final concentration). Optimal concentration should be validated per cell line.

Do you offer test samples before committing to a full order?

Yes. Complimentary test volumes are available on request for all human serum products. Contact us at info@seamlessbio.de to request a free sample.

Are your products suitable for GMP processes?

Our standard products are Research Use Only (RUO). For GMP-adjacent applications and clinical research, we provide enhanced documentation packages (CoA, donor certificates, viral validation reports). Please contact us for details.

What is the difference between heat-inactivated and gamma-irradiated serum?

Heat inactivation (56°C, 30 min) eliminates complement activity – important for hematopoietic cells and immunoassays. Gamma irradiation (25–45 kGy) provides additional pathogen reduction (viruses, mycoplasma) for biosafety-critical applications. Both treatments can be combined on request.

Recently Viewed Products